ATTANASIO, MONICA
 Distribuzione geografica
Continente #
NA - Nord America 4.855
EU - Europa 4.318
AS - Asia 1.889
SA - Sud America 249
AF - Africa 43
OC - Oceania 38
Continente sconosciuto - Info sul continente non disponibili 1
Totale 11.393
Nazione #
US - Stati Uniti d'America 4.793
PL - Polonia 1.303
RU - Federazione Russa 1.014
IT - Italia 752
SG - Singapore 530
CN - Cina 440
HK - Hong Kong 311
IE - Irlanda 260
DE - Germania 256
SE - Svezia 255
VN - Vietnam 231
BR - Brasile 203
KR - Corea 152
UA - Ucraina 152
FI - Finlandia 91
FR - Francia 84
GB - Regno Unito 81
IN - India 55
AU - Australia 38
CA - Canada 38
JP - Giappone 32
ID - Indonesia 21
TR - Turchia 21
NL - Olanda 20
AR - Argentina 17
JO - Giordania 17
ES - Italia 16
IQ - Iraq 16
MX - Messico 15
BD - Bangladesh 10
CI - Costa d'Avorio 10
BE - Belgio 7
NG - Nigeria 7
PH - Filippine 7
PK - Pakistan 7
AE - Emirati Arabi Uniti 6
CL - Cile 6
EC - Ecuador 6
KE - Kenya 6
SC - Seychelles 6
AZ - Azerbaigian 5
CH - Svizzera 5
TW - Taiwan 5
VE - Venezuela 5
SA - Arabia Saudita 4
ZA - Sudafrica 4
AL - Albania 3
BG - Bulgaria 3
BO - Bolivia 3
CO - Colombia 3
IR - Iran 3
NP - Nepal 3
PY - Paraguay 3
CZ - Repubblica Ceca 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
ET - Etiopia 2
IL - Israele 2
LB - Libano 2
LT - Lituania 2
LV - Lettonia 2
PE - Perù 2
PS - Palestinian Territory 2
TH - Thailandia 2
UZ - Uzbekistan 2
AI - Anguilla 1
AO - Angola 1
AT - Austria 1
BF - Burkina Faso 1
CR - Costa Rica 1
EG - Egitto 1
GA - Gabon 1
GP - Guadalupe 1
GR - Grecia 1
GT - Guatemala 1
GY - Guiana 1
KG - Kirghizistan 1
KW - Kuwait 1
KZ - Kazakistan 1
MA - Marocco 1
MD - Moldavia 1
MK - Macedonia 1
NI - Nicaragua 1
NO - Norvegia 1
PA - Panama 1
PR - Porto Rico 1
PT - Portogallo 1
RO - Romania 1
RS - Serbia 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
SX - ???statistics.table.value.countryCode.SX??? 1
TN - Tunisia 1
Totale 11.393
Città #
Warsaw 1.303
Santa Clara 1.076
Ashburn 459
Fairfield 393
Singapore 335
Chandler 297
Dublin 258
Hong Kong 252
Jacksonville 238
Seattle 168
Houston 153
Cambridge 147
Woodbridge 146
Seoul 144
Wilmington 144
Florence 119
Milan 108
Beijing 103
San Jose 92
Buffalo 76
Hefei 68
Ho Chi Minh City 66
Rome 66
Princeton 65
Boardman 61
Dallas 58
Ann Arbor 56
Lauterbourg 55
The Dalles 52
Boston 49
Altamura 48
Hanoi 48
Los Angeles 47
New York 44
Lawrence 39
Melbourne 36
Moscow 35
Munich 35
Medford 30
San Diego 30
Mumbai 28
Council Bluffs 27
Shanghai 27
Helsinki 22
Tokyo 20
Bologna 18
Kent 18
Jakarta 16
Campi Bisenzio 15
Da Nang 14
Naples 14
Phoenix 14
London 13
Paris 13
Turin 13
Norwalk 12
San Francisco 12
Turku 12
West Jordan 12
Orem 11
Abidjan 10
Brooklyn 10
Dong Ket 10
Figino 10
Frankfurt am Main 10
São Paulo 10
Toronto 10
Trieste 10
Yubileyny 10
Bari 9
Chennai 9
Frankfurt Am Main 9
Latina 9
Redondo Beach 9
Verona 9
Amsterdam 8
Atlanta 8
Auburn Hills 8
Baghdad 8
Capaccio 8
Izmir 8
Palermo 8
Rio de Janeiro 8
Abuja 7
Brussels 7
Catania 7
Genoa 7
Haiphong 7
Porto Alegre 7
Barcelona 6
Columbus 6
Guangzhou 6
Laguna de Duero 6
Manaus 6
Vancouver 6
Andover 5
Baku 5
Belo Horizonte 5
Brescia 5
Bắc Ninh 5
Totale 7.641
Nome #
Searching for a common mechanism for placenta mediated pregnancy complications and cardiovascular disease: role of Lipoprotein (a) 392
Transient intermittent lymphocyte activation is responsible for the instability of angina. 345
CYTOKINE GENE EXPRESSION AND PRODUCTION BY HUMAN LPS-STIMULATED MONONUCLEAR CELLS ARE INHIBITED BY SULFATED HEPARIN-LIKE SEMI-SYNTHETIC DERIVATIVES. 345
Evidence for oxidative stress in plasma of patients with Marfan syndrome 344
Identification of fibrillin 1 gene mutations in patients with bicuspid aortic valve (BAV) without Marfan syndrome. 311
PPARgamma promoter polymorphisms and acute coronary syndromes 308
Thrombin potential and traditional coagulation assay: are they useful in exploring recurrent pregnancy loss risk? 285
Vascular and connective tissue features in 5 italian patients with homocystinuria 283
Residual thrombin potential predicts cardiovascular death in acute coronary syndrome patients undergoing percutaneous coronary intervention 279
May TGFBR1 act also as low penetrance ellele in marfan syndrome? 252
Role of TGFBR1 and TGFBR2 genetic variants in Marfan syndrome 244
Homocysteine, vitamin B status and MTHFR polymorphisms in Italian infertile women 226
AGT and ACE genes influence classic mitral valve prolapse predisposition in Marfan patients 214
FBN1 mutation screening of patients with Marfan syndrome and related disorders: detection of 46 novel FBN1 mutations. 214
Acute-phase proteins and interleukin 6 serum level in head and neck cancer. 211
Association of Marfan syndrome and bicuspid aortic valve: Frequency and outcome 210
Interleukin-1 beta and interleukin-6 release by peripheral blood monocytes in head and neck cancer. 207
A single heterozygous nucleotide substitution displays two different altered mechanisms in the FBN1 gene of five Italian Marfan patients 207
Monocyte tumor necrosis factor production in head and neck squamous cell carcinoma. 192
Fibroblast autofluorescence in connective tissue disorders: a future tool for clinical and differential diagnosis? 192
Safe and Successful Surgical Outcome in Persons with Hemophilia A with and without Inhibitors Treated with Emicizumab: A Large, Single Center, Real-World Experience 181
Atherosclerosis and endometriosis: the role of diet and oxidative stress in a gender-specific disorder 178
Is ectopia lentis in some cases a mild phenotypic expression of Marfan syndrome? Need for a long-term follow-up. 178
Cyclooxygenase and lipoxygenase metabolite synthesis by polymorphonuclear neutrophilis: in vitro effect of dipyrone 172
A major involvment of the cardiovascular system in patients affected by Marfan syndrome: novel mutations in fibrillin 1 gene. 170
Effect of low-dose heparin on fibrinogen levels in patients with chronic ischemic heart disease. 170
Two case of Hermansky-Pudlak Syndrome associated with novel mutations in HPS3 and HPS6 genes. 169
Dural ectasia and FBN1 mutation screening of 40 patients with Marfan syndrome and related disorders: Role of dural ectasia for the diagnosis. 167
Ectopic Fat Depots and Cardiometabolic Burden: A Possible Dangerous Liaison in Women Planning Assisted Reproduction 167
Polyamines in the small intestine of rats after whole-body irradiation. 164
Heparin, monocytes, and procoagulant activity 163
Defibrotide reduces monocyte PAI-2 and procoagulant activity. 162
FIBRILLIN-1 (FBN1) GENE FRAMESHIFT MUTATIONS IN MARFAN PATIENTS: GENOTYPE-PHENOTYPE CORRELATION 158
Factors VIII and Von Willebrand Levels in Women Undergoing Assisted Reproduction: Are Their Levels Associated with Clinical Pregnancy Outcome? 157
Interleukin-6 and acute-phase proteins in head and neck cancer. 152
Haemostasis and Cytokines Modifications in Elite Cyclists 151
Diastolic subclinical primary alterations in Marfan syndrome and Marfan related disorders 149
Post-PCI thrombin generation and cardiovascular mortality in acute coronary syndrome patients 145
Interleukin-6 serum level and monocyte production in head and neck cancer 141
Heterogeneity in world distribution of the thermolabile C677T mutation in 5,10-methylenetetrahydrofolate reductase. 138
Tumor necrosis factor production by peripheral monocytes from head neck cancer patients. 138
Low-dose heparin as an antithrombotic agent 136
Monocyte activation and increased procoagulant activity in unstable angina 136
Tissue factor and plasminogen activator inhibitor type 2 expression in human stimulated monocytes is inhibited by heparin. 136
Lupus anticoagulant and monocyte procoagulant activity in polyabortive women. 135
Tissue factor reduction and tissue factor pathway inhibitor release after heparin administration. 135
Prevalence of factor V Leiden mutation in non-European populations. 130
Marfan's syndrome. Clinical and molecular characterization of 51 italian patients 127
Sex related differences in platelet TxA2 generation 125
Interleuckin-6 and Acute-phase protein in head and neck cancer(HNC) 122
Multiple primary tumors of the upper aerodigestive tract: is there a role for constitutional mutations in the p53 gene? 119
Monitoring of low-molecular-weight heparins in cardiovascular disease. 117
Espressione di mRNA per la p53 in adenomi parotidei e carcinomi squamocellulari della regione testa-collo. Identificazione e caratterizzaziuone di una mutazione p53 finora mai descritta 117
Different distribution of the double mutant "T833C/68 bp insertion" in cystathionine beta-synthase gene in Northern and Southern Italian populations. 116
Produzione monocitaria di interleukina 1 beta (IL-1beta) e interleuchina 6 (IL-6)nei tumori del cavo orofaringeo 112
Impact of cardiovascular burden on coagulation pathway in apparently healthy women planning oocyte donation 110
Cytokine gene expression in human LPS- and IFNgamma-stimulated mononuclear cells is inhibited by heparin. 105
MONOCYTE RECEPTOR EXPOSITION IS INFLUENCED BY CELL ACTIVATION 102
AORTA TORACICA: ASPETTI BIOMOLECOLARI E DI GENETICA CLINICA. 102
Thoracic aortic aneurysm. New evidence for fibrillin-1 involvement 100
Interleukina 6 (IL-6) e proteine della fase acuta n tumori del cavo orofaringeo 100
Prevalence of cardiovascular manifestations in Marfan syndrome 99
Produzione di IL-1beta, TNF-alfa e di IL-6 in monociti di pazienti con carcinoma delle V.A.D.S. 97
Microheterogeneity in the distribution of the 844ins68 in the cystathionine beta-synthase gene in Italy. 90
p53 and IL 6 expression in head and neck Cancer 77
Impaired platelet function in Hermansky-Pudlak syndrome associated with novel mutations in HPS3, HPS6 and HPS8 genes 52
null 10
Totale 11.438
Categoria #
all - tutte 29.207
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 29.207


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022416 14 34 24 19 20 16 12 29 14 18 96 120
2022/20231.102 104 174 55 103 94 200 151 50 113 7 28 23
2023/2024481 16 47 72 50 24 84 23 85 12 31 29 8
2024/20252.892 89 270 197 422 872 430 46 163 179 71 91 62
2025/20262.851 318 380 201 185 316 120 309 158 159 182 84 439
2026/2027125 125 0 0 0 0 0 0 0 0 0 0 0
Totale 11.438